The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis

SE Stutterheim, M van Dijk, H Wang, KJ Jonas - PloS one, 2021 - journals.plos.org
Introduction Transgender individuals are at risk for HIV. HIV risks are dynamic and there
have been substantial changes in HIV prevention (eg, pre-exposure prophylaxis [PrEP]). It is …

Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review

KH Mayer, A Agwu, D Malebranche - Advances in therapy, 2020 - Springer
Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first
approved by the US Food and Drug Administration in 2012. Despite correlations of …

Standards of care for the health of transgender and gender diverse people, version 8

E Coleman, AE Radix, WP Bouman… - … journal of transgender …, 2022 - Taylor & Francis
Background: Transgender healthcare is a rapidly evolving interdisciplinary field. In the last
decade, there has been an unprecedented increase in the number and visibility of …

Improving PrEP implementation through multilevel interventions: a synthesis of the literature

RM Pinto, KR Berringer, R Melendez, O Mmeje - AIDS and Behavior, 2018 - Springer
There are many challenges to accessing PrEP and thus low uptake in the United States.
This review (2007–2017) of PrEP implementation identified barriers to PrEP and …

A paradigm for understanding trust and mistrust in medical research: the Community VOICES study

M Smirnoff, I Wilets, DF Ragin, R Adams… - AJOB empirical …, 2018 - Taylor & Francis
Background: To promote justice in research practice and rectify health disparities, greater
diversity in research participation is needed. Lack of trust in medical research is one of the …

A gap between willingness and uptake: findings from mixed methods research on HIV prevention among black and Latina transgender women

T Poteat, A Wirtz, M Malik, E Cooney… - JAIDS Journal of …, 2019 - journals.lww.com
Background: Black and Latina transgender women (BLTW) face significant HIV disparities
with estimated HIV prevalence up to 50% and annual incidence rates as high as 2.8 per 100 …

The roles of gender affirmation and discrimination in the resilience of transgender individuals in the US

C Lelutiu-Weinberger, D English… - Behavioral …, 2020 - Taylor & Francis
Transgender individuals face severe stigma-driven health inequities structurally,
institutionally, and interpersonally, yielding poor individual-level outcomes. Gender …

How has HIV pre-exposure prophylaxis (PrEP) changed sex? A review of research in a new era of bio-behavioral HIV prevention

C Grov, DA Westmoreland, AB D'Angelo… - The Journal of Sex …, 2021 - Taylor & Francis
In 2012, the US FDA approved the first drug for use as HIV Pre-Exposure Prophylaxis
(PrEP), which is nearly 99% effective when taken as prescribed. Although the manifest …

Barriers and facilitators to oral PrEP use among transgender women in New York City

CT Rael, M Martinez, R Giguere, W Bockting… - AIDS and Behavior, 2018 - Springer
Transgender women may face a disparate risk for HIV/AIDS compared to other groups. In
2012, Truvada was approved for daily use as HIV pre-exposure prophylaxis (PrEP) …

Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication

SB Bass, PJ Kelly, J Brajuha, L Gutierrez-Mock… - BMC public health, 2022 - Springer
Background Trans women are at increased risk for HIV infection yet are less likely to use pre-
exposure prophylaxis (PrEP) medication as a preventive measure. PrEP messaging and …